ストックスクリーナーアプリを入手
20.22
136.27%
11.70
アフターアワーズ：
18.69
-1.53
-7.57%
前日終値:
$8.52
開ける：
$26.455
24時間の取引高:
85.50M
Relative Volume:
34.92
時価総額：
$584.98M
収益：
-
当期純損益:
$-96.66M
株価収益率:
-9.4047
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+145.79%
1か月 パフォーマンス:
+115.06%
6か月 パフォーマンス:
+327.39%
1年 パフォーマンス:
+133.26%
1日の値動き範囲:
$18.11
$27.17
1週間の範囲:
$7.82
$27.17
52週間の値動き範囲:
$2.86
$27.17
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
20.22 | 584.98M | 0 | -96.66M | -83.73M | -2.15 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-12 | 繰り返されました | Citigroup | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
OLMA: HC Wainwright & Co. Raises Price Target to $36 with a Buy Rating | OLMA Stock News - GuruFocus
Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock - Benzinga
Positive Outlook for Olema’s OPERA-02 Study Following Roche’s Successful Phase 3 Trial Results - TipRanks
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
JP Morgan Raises Price Target for OLMA to $32.00, Maintains Overweight Rating | OLMA Stock News - GuruFocus
Olema Pharmaceuticals (OLMA) Surges on Roche's Breast Cancer Tri - GuruFocus
Olema Pharma (OLMA) Stock Rallies Following Competitor Roche’s Cancer Trial Breakthrough - parameter.io
Cancer Focused Olema Pharmaceuticals Stock Soars 150%Here's Why - Benzinga
Olema Pharmaceuticals Stock (OLMA) Opinions on Strategic Collaboration Announcement - Quiver Quantitative
Why Is Olema Pharmaceuticals Stock (OLMA) Up Today? - TipRanks
Roche boosts Olema after breast cancer trial win (RHHBY) - Seeking Alpha
Is Olema Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Olema Pharmaceuticals, Inc. $OLMA Holdings Raised by Persistent Asset Partners Ltd - MarketBeat
How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
Can Olema Pharmaceuticals Inc. stock double in next 5 yearsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Forecasting Olema Pharmaceuticals Inc. price range with options dataJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. reboundWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
News impact scoring models applied to Olema Pharmaceuticals Inc.Portfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6.3%Time to Buy? - MarketBeat
Sector ETF performance correlation with Olema Pharmaceuticals Inc.Trend Reversal & High Conviction Trade Alerts - newser.com
What Wall Street predicts for Olema Pharmaceuticals Inc. stock price - Fundação Cultural do Pará
How to build a dashboard for Olema Pharmaceuticals Inc. stockBreakout Watch & Verified High Yield Trade Plans - newser.com
FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital - MarketBeat
Analysts Set Expectations for OLMA FY2025 Earnings - MarketBeat
Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Update & Stepwise Trade Signal Guides - Fundação Cultural do Pará
Olema Pharmaceuticals Inc. stock momentum explainedTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Optimistic Buy Rating for Olema Pharmaceuticals Driven by Promising Palazestrant Developments - TipRanks
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 7.2% After Earnings Miss - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastPrice Support Zones & High Profit Market Ideas - earlytimes.in
Why Olema Pharmaceuticals Inc. stock could rally in 2025Trade Volume Summary & Safe Entry Zone Tips - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - TipRanks
Optimistic Buy Rating for Olema Pharmaceuticals Driven by Unique Phase III Trials and Promising Market Potential - TipRanks
Will Olema Pharmaceuticals Inc. continue its uptrend2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Olema Oncology (OLMA) Advances Cancer Treatment Trials - GuruFocus
Olema Pharma Q3 net loss widens - MarketScreener
[10-Q] Olema Pharmaceuticals, Inc. Quarterly Earnings Report | OLMA SEC FilingForm 10-Q - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Olema (NASDAQ: OLMA) reports $329M cash, starts OPERA-02 and Pfizer combo study - Stock Titan
Will Olema Pharmaceuticals Inc. stock go up soonTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Has Olema Pharmaceuticals Inc. found a price floorQuarterly Profit Report & AI Powered Market Trend Analysis - newser.com
How geopolitical tensions affect Olema Pharmaceuticals Inc. stock2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
How Olema Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Olema Pharmaceuticals, Inc. (OLMA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
Olema Pharmaceuticals Inc (OLMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.04 |
10,000 |
80,400 |
754,140 |
| Harmon Cyrus | Director |
Sep 18 '25 |
Sale |
8.32 |
3,086 |
25,676 |
117,028 |
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.08 |
1,914 |
15,465 |
120,114 |
2.12%
0.33%
大文字化:
|
ボリューム (24 時間):